Mechanistically, it was found that this worked through the PI3K/mTOR pathway rather than the JAK/STAT pathway, in both the previously mentioned lung cancer model and a breast cancer model (although not KRAS-mutant) [83,84]. This evidence concerns the gene KRAS and lung carcinoma.